Barlas, S. (2017). Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA on Off-Label Promotion? P T.
Stile di citazione ChicagoBarlas, Stephen. "Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA On Off-Label Promotion?" P T 2017.
Citazione MLABarlas, Stephen. "Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA On Off-Label Promotion?" P T 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.